Connected MOM Plus for Blood Pressure Monitoring in Pregnancy
This study, called Connected MOM Plus, is looking at ways to improve how pregnant and postpartum (after birth) women monitor their blood pressure, especially those who might have trouble getting healthcare. It's testing if extra support from a 'navigator' helps women use the Connected MOM program more consistently. This program aims to help manage conditions like high blood pressure during pregnancy. You might be able to join if you are a woman between 18 and 80 years old, have a smartphone, understand English or Spanish, have a participating Ochsner doctor, plan to deliver at a participating Ochsner hospital, and live in a specific zip code. The study will measure how well the Connected MOM program is used by looking at enrollment and blood pressure readings over 6-9 months. The current recruitment status is unclear.
- Study design
- This is an interventional study planning to include 2000 participants. It is a quality improvement initiative to improve the use of the Connected MOM program.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants' blood pressure measurements and program use will be followed for 6-9 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Implementation Models for Blood Pressure Monitoring in Pregnancy and Postpartum: Connected MOM Plus
At a glance
Conditions
NCT07691541
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Ochsner Health
New Orleans, Louisianastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Emily W Harville, PhD · PRINCIPAL_INVESTIGATOR · Tulane University Weatherhead School of Public Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Successful use of the intervention and control programs measured by enrollment aggregate6-9 months
Aggregate enrollment in the intervention or control arms by 25 weeks of gestation relative to the total number of eligible participants. This will be measured by the total number of women participating in the Connected MOM or Connected MOM+ divided by the total number of eligible pregnant women presenting to the hospital.
- Successful use of the intervention and control programs as determined by the systolic and diastolic blood pressure measurements6-9 months
This is determined by measuring the systolic and diastolic blood pressure in mmHg at least once per week during pregnancy.
- Successful use of the intervention and control programs as determined by postpartum blood pressure measurement6-9 months
This is determined by measuring at least one postpartum blood pressure measurement (systolic and diastolic) in mmHg before a postpartum visit.
- Adequacy of prenatal care6-9 months
Adequacy of prenatal care will be measured using the Kotelchuck index, a score that assesses the adequacy of maternal health care. The score ranges from 0% to above, with higher scores indicating better maternal health care.
- Adverse composite maternal outcome6-9 months
pre-eclampsia without severe features (\~5%), pre-eclampsia with severe features (1-2%), HELLP syndrome; eclampsia (rare), preterm delivery \< 37 weeks (spontaneous or indicated) (12-15%), SMM without transfusion included (around 2-3%), maternal mortality